Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy [1]

Acta Dermato-Venereologica

Volumn 83, Issue 1, 2003, Pages 49-50

  Radenhausen, Michael ^a   Von Kobyletzki, Gregor ^a   Höxtermann, Stefan ^a   Altmeyer, Peter ^a   Hoffmann, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; EMOLLIENT AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 2 RECEPTOR; METHOXSALEN;

ADULT; AGED; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; LEUKAPHERESIS; LEUKOCYTE; MALE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIATION DOSE; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

ADULT; AGED; BLOOD PROTEINS; DERMATITIS, ATOPIC; E-SELECTIN; EOSINOPHIL GRANULE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; RECEPTORS, INTERLEUKIN-2; RIBONUCLEASES;

EID: 0037279917     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310002710     Document Type: Letter

References (15)

1. Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 1982; 6: 1-13.
2. Furue M, Koga T, Yamashita N. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999; 140: 67-72.
3. Colver GB, Symons JA, Duff GW. Soluble interleukin 2 receptor in atopic eczema. BMJ 1998; 298: 1426-1427.
4. Spring TA. Traffic signal for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
5. Owsianowski M, Garbe C, Ramaker J, Orfanos CE, Gollnick H. Therapeutische Erfahrungen mit der extra-korporalen Photopherese. Hautarzt 1996; 47: 114-123.
6. Prinz B, Michelsen S, Pfeiffer Ch, Plewig G. Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 1999; 40: 577-582.
7. Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994; 287: 48-52.
8. Richter HI, Billmann-Eberwein C, Grewe M, Stege H, Berneburg M, Ruzicka T, et al. Successful monotherapy of severe and intractable atopic dermatitis by photopheresis. J Am Acad Dermatol 1998; 38: 585-588.
9. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
10. Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K, et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
11. Tokura Y, Seo N, Hiroaki Y, Wakita H, Moriwaki S, Furukawa F, et al. Treatment of T-lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol 1999; 113: 202-208.
12. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneus T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-242.
13. Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with clinical activity of atopic dermatitis. Dermatology 1992; 185: 88-92.
14. von Kobyletzki G, Piek C, Höxtermann S, Freitag M, Altmeyer P. Circulating activation markers of severe atopic dermatitis following ultraviolet A1 cold light phototherapy: eoslnophil cationic protein, soluble interleukin-2 receptor and soluble interleukin-4 receptor. Br J Dermatol 1999; 140: 966-967.
15. Czech W, Schopf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis-correlation with disease activity. Br J Dermatol 1996; 134: 17-21.